IP Library Granted Patent US 10,028,723
Granted Patent B2
US 10,028,723 · App. 14/476,543 · Granted Jul 24, 2018

Systems and methods for real-time, transcranial monitoring of blood-brain barrier opening

Inventors: Elisa E. Konofagou (New York, NY); Tobias Teichert (New York, NY); Vincent P. Ferrera (New York, NY); Fabrice Marquet (New York, NY); Yao-Sheng Teng (New York, NY); Shih-Ying Wu (New York, NY)
Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
A61B8/0808A61B8/4281A61B8/5223A61N7/02A61B8/481A61B2090/378A61N2007/0039A61N2007/0052A61N2007/0091
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,028,723
App. No.
14/476,543
Granted
Jul 24, 2018
Kind
B2
Abstract

Systems and techniques for real-time, transcranial monitoring of safe blood-brain barrier opening include determining an approach angle for targeted blood-brain barrier opening proximate a predetermined region in a brain of a patient, and positioning an ultrasound transducer to generate a focused ultrasound signal at the determined approach angle to the predetermined region in the brain.

Claims (31)

1. A system for real-time, transcranial monitoring of safe blood-brain barrier opening, comprising:

an ultrasound transducer;

a monitoring component configured to transcranially monitor opening of the blood-brain barrier by acquiring an emission from a microbubble; and

a targeting component, coupled to the ultrasound transducer and configured to:

determine an approach angle for targeted blood-brain barrier opening proximate a predetermined region in a brain of a patient, and

position the ultrasound transducer to generate a ultrasound signal at the determined approach angle to the predetermined region in the brain.

2. The system according to claim 1 , wherein the ultrasound transducer operates at an intermediate frequency of 500 kHz.

3. The system according to claim 1 , wherein the targeting component is configured to target the predetermined region of the brain without use of a magnetic resonance image monitoring.

4. The system according to claim 1 , wherein the targeting component comprises a stereotactic manipulator to target the predetermined region in the brain.

5. The system according to claim 1 , wherein the monitoring component monitors a frequency of a backscattered acoustic signal generated from the microbubble in response to the targeting by the ultrasound transducer.

6. The system according to claim 1 , wherein the monitoring component comprises a passive cavitation detector.

7. The system of claim 1 , wherein the approach angle for targeted blood-brain barrier opening transcends a skull of the patient.

8. The system according to claim 1 , wherein the monitoring component is configured to perform a noninvasive real-time monitoring.

9. The system according to claim 1 , wherein the ultrasound signal is a focused ultrasound signal.

10. A method for real-time, transcranial monitoring of safe blood-brain barrier opening, comprising:

providing an ultrasound transducer;

determining an approach angle for targeted blood-brain barrier opening proximate a predetermined region in a brain of a patient; and

positioning the ultrasound transducer to generate a ultrasound signal at the determined approach angle to the predetermined region in the brain;

administering microbubbles to the patient;

generating the ultrasound signal at the determined approach angle to the predetermined region in the brain; and

monitoring an occurrence of the blood-brain barrier opening by transcranially acquiring an emission from the microbubbles.

11. The method according to claim 10 , further comprising operating the ultrasound transducer at an intermediate frequency of 500 kHz.

12. The method according to claim 10 , further comprising targeting the predetermined region of the brain without use of a magnetic resonance image monitoring.

13. The method according to claim 10 , further comprising targeting the predetermined region in the brain using a stereotactic manipulator.

14. The method according to claim 10 , wherein the monitoring is performed by acquiring a frequency of a backscattered acoustic signal generated from the microbubbles in response to the targeting by the ultrasound transducer.

15. The method according to claim 10 , wherein the monitoring is performed using a passive cavitation detector.

16. The method according to claim 10 , wherein the patient is anesthetized during the blood-brain barrier opening.

17. The method according to claim 10 , wherein the patient is awake during the blood-brain barrier opening.

18. The method of claim 10 , wherein the approach angle for targeted blood-brain barrier opening transcends a skull of the patient.

19. The method according to claim 10 , wherein the monitoring is noninvasive and real-time.

20. The method according to claim 10 , wherein the ultrasound signal is a focused ultrasound signal.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 5, 2018
From: KONOFAGOU, ELISA E.; TEICHERT, TOBIAS; FERRERA, VINCENT P.; MARQUET, FABRICE; TUNG, YAO-SHENG; WU, SHIH-YING
To: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
Reel/Frame 046434/0001 →
CONFIRMATORY LICENSE Recorded Nov 24, 2014
From: COLUMBIA UNIV NEW YORK MORNINGSIDE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 034432/0755 →
Continuity (2)
Provisional Application 61873310 · Sep 3, 2013
Related Publication 20150065871A1 · Mar 5, 2015
Cited By (1)
US 12,485,297